Vpriv is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Vpriv is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameVpriv
Authorized genericvelaglucerase alfa
Regular genericvelaglucerase alfa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Vpriv?
The original
–
–

Brand nameThe maker’s card

Takeda Patient Support Co-Pay Assistance Program

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.
Insurance · up to $20,000 off a year

The card takes up to $20,000 a year off your co-pay.

Sign up on takedapatientsupport.com 

In the maker’s words

“The maximum co-pay assistance available annually is $20,000 ($40,000 for hereditary angioedema treatment, $10,000 for cytomegalovirus).”

From the maker’s offer on takedapatientsupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Vpriv itself, from the same company, sold without the brand name, and usually for less. For now Vpriv is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Vpriv is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VPRIV is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.

Source: the FDA label for Vpriv (Takeda Pharmaceuticals America, Inc.), November 26, 2024. Full label on DailyMed 

Good to know